244 related articles for article (PubMed ID: 26796350)
1. Circulating Cell Death Biomarkers May Predict Survival in Human Lung Transplantation.
Hashimoto K; Besla R; Zamel R; Juvet S; Kim H; Azad S; Waddell TK; Cypel M; Liu M; Keshavjee S
Am J Respir Crit Care Med; 2016 Jul; 194(1):97-105. PubMed ID: 26796350
[TBL] [Abstract][Full Text] [Related]
2. Higher M30 and high mobility group box 1 protein levels in ex vivo lung perfusate are associated with primary graft dysfunction after human lung transplantation.
Hashimoto K; Cypel M; Juvet S; Saito T; Zamel R; Machuca TN; Hsin M; Kim H; Waddell TK; Liu M; Keshavjee S
J Heart Lung Transplant; 2017 Jun; ():. PubMed ID: 28689646
[TBL] [Abstract][Full Text] [Related]
3. Increased Extravascular Lung Water and Plasma Biomarkers of Acute Lung Injury Precede Oxygenation Impairment in Primary Graft Dysfunction After Lung Transplantation.
Pottecher J; Roche AC; Dégot T; Helms O; Hentz JG; Schmitt JP; Falcoz PE; Santelmo N; Levy F; Collange O; Uring-Lambert B; Bahram S; Schaeffer M; Meyer N; Geny B; Lassalle P; Diemunsch P; Massard G; Kessler R; Steib A;
Transplantation; 2017 Jan; 101(1):112-121. PubMed ID: 27495752
[TBL] [Abstract][Full Text] [Related]
4. Epithelial cell death markers in bronchoalveolar lavage correlate with chronic lung allograft dysfunction subtypes and survival in lung transplant recipients-a single-center retrospective cohort study.
Levy L; Tigert A; Huszti E; Saito T; Mitsakakis N; Moshkelgosha S; Joe B; Boonstra KM; Tikkanen JM; Keshavjee S; Juvet SC; Martinu T
Transpl Int; 2019 Sep; 32(9):965-973. PubMed ID: 31002407
[TBL] [Abstract][Full Text] [Related]
5. The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia.
Diamond JM; Porteous MK; Roberts LJ; Wickersham N; Rushefski M; Kawut SM; Shah RJ; Cantu E; Lederer DJ; Chatterjee S; Lama VN; Bhorade S; Crespo M; McDyer J; Wille K; Orens J; Weinacker A; Arcasoy S; Shah PD; Wilkes DS; Hage C; Palmer SM; Snyder L; Calfee CS; Ware LB; Christie JD;
J Heart Lung Transplant; 2016 Apr; 35(4):500-507. PubMed ID: 26856667
[TBL] [Abstract][Full Text] [Related]
6. Construct validity of the definition of primary graft dysfunction after lung transplantation.
Christie JD; Bellamy S; Ware LB; Lederer D; Hadjiliadis D; Lee J; Robinson N; Localio AR; Wille K; Lama V; Palmer S; Orens J; Weinacker A; Crespo M; Demissie E; Kimmel SE; Kawut SM
J Heart Lung Transplant; 2010 Nov; 29(11):1231-9. PubMed ID: 20655249
[TBL] [Abstract][Full Text] [Related]
7. Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantation.
Shah RJ; Diamond JM; Lederer DJ; Arcasoy SM; Cantu EM; Demissie EJ; Kawut SM; Kohl B; Lee JC; Sonett J; Christie JD; Ware LB
Transl Res; 2012 Dec; 160(6):435-42. PubMed ID: 22989614
[TBL] [Abstract][Full Text] [Related]
8. Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?
Bilici A; Ustaalioglu BB; Ercan S; Orcun A; Seker M; Salepci T; Gumus M
Cancer Chemother Pharmacol; 2011 Aug; 68(2):309-16. PubMed ID: 20967544
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer.
de Haas EC; di Pietro A; Simpson KL; Meijer C; Suurmeijer AJ; Lancashire LJ; Cummings J; de Jong S; de Vries EG; Dive C; Gietema JA
Neoplasia; 2008 Oct; 10(10):1041-8. PubMed ID: 18813353
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum M30 and M65 levels in melanoma.
Tas F; Karabulut S; Serilmez M; Yildiz I; Sen F; Ciftci R; Duranyildiz D
Melanoma Res; 2013 Oct; 23(5):390-5. PubMed ID: 23812330
[TBL] [Abstract][Full Text] [Related]
11. Diastolic Dysfunction Increases the Risk of Primary Graft Dysfunction after Lung Transplant.
Porteous MK; Ky B; Kirkpatrick JN; Shinohara R; Diamond JM; Shah RJ; Lee JC; Christie JD; Kawut SM
Am J Respir Crit Care Med; 2016 Jun; 193(12):1392-400. PubMed ID: 26745666
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and survival impact of primary graft dysfunction after lung transplantation in a single institution.
Samano MN; Fernandes LM; Baranauskas JC; Correia AT; Afonso JE; Teixeira RH; Caramori ML; Pêgo-Fernandes PM; Jatene FB
Transplant Proc; 2012 Oct; 44(8):2462-8. PubMed ID: 23026621
[TBL] [Abstract][Full Text] [Related]
13. Improved survival but marginal allograft function in patients treated with extracorporeal membrane oxygenation after lung transplantation.
Hartwig MG; Walczak R; Lin SS; Davis RD
Ann Thorac Surg; 2012 Feb; 93(2):366-71. PubMed ID: 21962264
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant.
Cantu E; Diamond JM; Suzuki Y; Lasky J; Schaufler C; Lim B; Shah R; Porteous M; Lederer DJ; Kawut SM; Palmer SM; Snyder LD; Hartwig MG; Lama VN; Bhorade S; Bermudez C; Crespo M; McDyer J; Wille K; Orens J; Shah PD; Weinacker A; Weill D; Wilkes D; Roe D; Hage C; Ware LB; Bellamy SL; Christie JD;
Am J Respir Crit Care Med; 2018 Jan; 197(2):235-243. PubMed ID: 28872353
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors for Mortality in 272 Patients With Lung Transplant: A Multicenter Analysis of 7 Intensive Care Units.
Rello J; Bello I; de Vicente R; Hermira Anchuelo A; Ballesteros MÁ; Iranzo R; Rellán L; Riera J; Robles JC;
Arch Bronconeumol; 2017 Aug; 53(8):421-426. PubMed ID: 28256290
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with early graft dysfunction in cystic fibrosis patients receiving primary bilateral lung transplantation.
Felten ML; Sinaceur M; Treilhaud M; Roze H; Mornex JF; Pottecher J; Journois D; Fischler M
Eur J Cardiothorac Surg; 2012 Mar; 41(3):686-90. PubMed ID: 22345188
[TBL] [Abstract][Full Text] [Related]
17. Prolonged Cold Ischemia Induces Necroptotic Cell Death in Ischemia-Reperfusion Injury and Contributes to Primary Graft Dysfunction after Lung Transplantation.
Wang X; O'Brien ME; Yu J; Xu C; Zhang Q; Lu S; Liang L; An X; McDyer JF; Mallampalli RK
Am J Respir Cell Mol Biol; 2019 Aug; 61(2):244-256. PubMed ID: 30742487
[TBL] [Abstract][Full Text] [Related]
18. Role of the postoperative cholesterol in early allograft dysfunction and survival after living donor liver transplantation.
Yang J; Wang HQ; Yang JY; Wen TF; Li B; Wang WT; Yan LN
Hepatobiliary Pancreat Dis Int; 2017 Dec; 16(6):610-616. PubMed ID: 29291780
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Extracorporeal Membrane Oxygenation for Primary Graft Dysfunction After Lung Transplantation.
Takahashi T; Terada Y; Pasque MK; Nava RG; Kozower BD; Meyers BF; Patterson GA; Kreisel D; Puri V; Hachem RR
Ann Thorac Surg; 2023 May; 115(5):1273-1280. PubMed ID: 36634836
[TBL] [Abstract][Full Text] [Related]
20. Plasma protein biomarkers for primary graft dysfunction after lung transplantation: a single-center cohort analysis.
Chacon-Alberty L; Kanchi RS; Ye S; Hochman-Mendez C; Daoud D; Coarfa C; Li M; Grimm SL; Baz M; Rosas I; Loor G
Sci Rep; 2022 Sep; 12(1):16137. PubMed ID: 36167867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
